Not Tagged
Not Tagged
['solid tumor']
ongoing clinical trial data on 18 patients treated with t cell antigen coupler (tac) technology presented by benjamin l. schlechter, md, ( ) at #asco23. tac technology is a novel approach to modifying t cells, allowing them to recognize and treat her2+ solid tumors. 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090